$453 Million is the total value of Parkman Healthcare Partners LLC's 84 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 22.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| UTHR | Sell | UNITED THERAPEUTICS CORP DEL | $19,490,000 | +11.9% | 90,198 | -4.4% | 4.30% | -2.4% |
| DXCM | Sell | DEXCOM INC | $17,669,000 | -28.9% | 32,906 | -27.6% | 3.90% | -38.0% |
| AVTR | Sell | AVANTOR INC | $17,175,000 | -4.6% | 407,575 | -7.4% | 3.79% | -16.8% |
| ACRS | Sell | ACLARIS THERAPEUTICS INC | $14,911,000 | -36.6% | 1,025,522 | -21.5% | 3.29% | -44.7% |
| COO | Sell | COOPER COS INC | $9,935,000 | -0.2% | 23,715 | -1.5% | 2.19% | -13.0% |
| ALNY | Sell | ALNYLAM PHARMACEUTICALS INC | $9,782,000 | -30.9% | 57,682 | -23.1% | 2.16% | -39.7% |
| CDMO | Sell | AVID BIOSERVICES INC | $8,462,000 | -12.8% | 290,000 | -35.6% | 1.87% | -24.0% |
| ABBV | Sell | ABBVIE INC | $7,003,000 | -13.4% | 51,722 | -31.0% | 1.54% | -24.5% |
| GOSS | Sell | GOSSAMER BIO INC | $6,180,000 | -37.5% | 546,421 | -30.6% | 1.36% | -45.5% |
| RCUS | Sell | ARCUS BIOSCIENCES INC | $4,739,000 | -42.6% | 117,099 | -50.5% | 1.05% | -49.9% |
| PODD | Sell | INSULET CORP | $4,523,000 | -53.7% | 17,000 | -50.5% | 1.00% | -59.6% |
| FULC | Sell | FULCRUM THERAPEUTICS INC | $4,424,000 | -53.7% | 250,106 | -26.2% | 0.98% | -59.6% |
| XRAY | Sell | DENTSPLY SIRONA INC | $4,104,000 | -12.1% | 73,566 | -8.6% | 0.91% | -23.4% |
| BCYC | Sell | BICYCLE THERAPEUTICS PLCsponsored ads | $3,944,000 | +36.3% | 64,800 | -6.8% | 0.87% | +18.9% |
| BRKS | Sell | AZENTA INC | $3,769,000 | -7.9% | 36,554 | -8.6% | 0.83% | -19.7% |
| KOD | Sell | KODIAK SCIENCES INC | $2,982,000 | -15.4% | 35,174 | -4.2% | 0.66% | -26.2% |
| RGEN | Sell | REPLIGEN CORP | $2,736,000 | -52.7% | 10,331 | -48.3% | 0.60% | -58.7% |
| ATEC | Sell | ALPHATEC HLDGS INC | $2,685,000 | -11.9% | 234,923 | -6.0% | 0.59% | -23.2% |
| STXS | Sell | STEREOTAXIS INC | $2,562,000 | +5.8% | 413,218 | -8.2% | 0.56% | -7.8% |
| IONS | Sell | IONIS PHARMACEUTICALS INC | $2,442,000 | -46.6% | 80,238 | -41.2% | 0.54% | -53.4% |
| MDGL | Sell | MADRIGAL PHARMACEUTICALS INC | $2,429,000 | -3.0% | 28,670 | -8.7% | 0.54% | -15.5% |
| OM | Sell | OUTSET MED INC | $2,181,000 | -12.4% | 47,317 | -6.0% | 0.48% | -23.7% |
| PFMT | Sell | PERFORMANT FINL CORP | $2,049,000 | -47.1% | 850,000 | -13.0% | 0.45% | -53.8% |
| SMLR | Sell | SEMLER SCIENTIFIC INC | $1,963,000 | -37.2% | 21,419 | -14.3% | 0.43% | -45.3% |
| REPH | Sell | RECRO PHARMA INC | $1,104,000 | -30.5% | 645,675 | -16.2% | 0.24% | -39.3% |
| ICAD | Sell | ICAD INC | $744,000 | -44.6% | 103,302 | -17.4% | 0.16% | -51.8% |
| ONCT | Sell | ONCTERNAL THERAPEUTICS INC | $657,000 | -51.6% | 289,280 | -11.1% | 0.14% | -57.7% |
| VERA | Sell | VERA THERAPEUTICS INCcl a | $576,000 | +29.4% | 21,555 | -15.9% | 0.13% | +12.4% |
| CALA | Exit | CALITHERA BIOSCIENCES INC | $0 | – | -100,628 | -100.0% | -0.06% | – |
| CBIO | Exit | CATALYST BIOSCIENCES INC | $0 | – | -133,449 | -100.0% | -0.14% | – |
| VCEL | Exit | VERICEL CORP | $0 | – | -20,340 | -100.0% | -0.25% | – |
| BBIO | Exit | BRIDGEBIO PHARMA INC | $0 | – | -57,978 | -100.0% | -0.69% | – |
| NOTV | Exit | INOTIV INC | $0 | – | -97,500 | -100.0% | -0.72% | – |
| DRNA | Exit | DICERNA PHARMACEUTICALS INC | $0 | – | -209,686 | -100.0% | -1.07% | – |
| AMGN | Exit | AMGEN INC | $0 | – | -20,000 | -100.0% | -1.08% | – |
| HUM | Exit | HUMANA INC | $0 | – | -19,000 | -100.0% | -1.87% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-02-11
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| DEXCOM INC | 16 | Q3 2023 | 6.3% |
| ACLARIS THERAPEUTICS INC | 16 | Q3 2023 | 10.0% |
| XENON PHARMACEUTICALS INC | 16 | Q3 2023 | 3.3% |
| NATERA INC | 16 | Q3 2023 | 3.4% |
| AVID BIOSERVICES INC | 15 | Q3 2023 | 2.9% |
| SCHRODINGER INC | 15 | Q3 2023 | 4.2% |
| REPRO MED SYS INC | 15 | Q2 2023 | 2.0% |
| MANNKIND CORP | 15 | Q3 2023 | 1.6% |
| IQVIA HLDGS INC | 14 | Q1 2023 | 4.6% |
| INSULET CORP | 14 | Q3 2023 | 2.9% |
View Parkman Healthcare Partners LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| PLUS THERAPEUTICS, INC. | February 13, 2023 | 583,467 | 1.7% |
View Parkman Healthcare Partners LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| SC 13G/A | 2023-02-13 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-13 |
View Parkman Healthcare Partners LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.